The decision was influenced by the positive recommendation from the EMA’s Committee for Medicinal Products for Human Use.

Antibiotic-resistant bacteria are a serious public health threat. Understanding the biology of these bacteria—such as how ...

Merck (MRK), known as MSD outside of the United States and Canada, announced that the European Commission, or EC, has approved CAPVAXIVE, or ...

US pharma giant Merck & Co (NYSE: MRK) today announced that the European Commission (EC) has approved Capvaxive (Pneumococcal ...

SINGAPORE: Antibiotic-resistant bacteria pose a significant threat to public health, and researchers from the Yong Loo Lin School of Medicine at the National Un ...

Antibiotic-resistant bacteria is a serious public health threat. Understanding the biology of these bacteria--such as how they synthesise their protective capsules--is essential for developing new ...

Merck & Co. has won approval from the European Commission of its Capvaxive pneumococcal disease vaccine for adults. The Rahway, N.J., drugmaker on Wednesday said the approval covers the 21-valent ...

Antibiotic-resistant bacteria is a serious public health threat. Understanding the biology of these bacteria -- such as how they synthesise their ...

Objective: To compare the safety and efficacy of clarithromycin and amoxicillin/clavulanic acid in patients with community-acquired pneumonia due to penicillin ...

In reality, pneumococcal pneumonia, caused by the Streptococcus pneumoniae bacteria, is a life-threatening lung infection that can strike suddenly and escalate rapidly. Lung Foundation of Malaysia ...

This is the third indication for Fabhalta after Novartis won FDA approval of the small molecule in paroxysmal nocturnal ...